|
TFCP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.911900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.699700E-02 |
| Normal-vs-Stage2 |
2.676200E-01 |
| Normal-vs-Stage3 |
2.140600E-01 |
| Normal-vs-Stage4 |
1.690000E-01 |
| Stage1-vs-Stage2 |
9.927800E-01 |
| Stage1-vs-Stage3 |
7.215600E-01 |
| Stage1-vs-Stage4 |
6.279000E-01 |
| Stage2-vs-Stage3 |
8.021400E-01 |
| Stage2-vs-Stage4 |
6.260000E-01 |
| Stage3-vs-Stage4 |
8.528200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.725700E-02 |
| Normal-vs-AfricanAmerican |
4.087600E-01 |
| Normal-vs-Asian |
1.809570E-01 |
| Caucasian-vs-AfricanAmerican |
6.861600E-01 |
| Caucasian-vs-Asian |
7.808600E-01 |
| AfricanAmerican-vs-Asian |
6.596200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.523500E-02 |
| Normal-vs-Female |
9.612200E-01 |
| Male-vs-Female |
1.028850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.937600E-02 |
| Normal-vs-Extreme_Weight |
2.989600E-02 |
| Normal-vs-Obese |
1.385760E-01 |
| Normal-vs-Extreme_Obese |
1.270820E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.015200E-01 |
| Normal_Weight-vs-Obese |
6.333400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.614800E-01 |
| Extreme_Weight-vs-Obese |
5.123000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.352800E-01 |
| Obese-vs-Extreme_Obese |
4.417400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.307400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.592600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.702400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.836400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.655800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.329400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.788000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.796240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.460190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.188600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.895800E-01 |
| Normal-VS-Type2 PRCC |
9.265000E-03 |
| Normal-VS-KIRP CIMP |
2.13950000049756E-07 |
| Normal-VS-Unclassified PRCC |
8.277000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.972400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.013500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.517800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.384500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.794500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.120800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.145600E-02 |
| Normal-vs-N1 |
8.011200E-01 |
| Normal-vs-N2 |
1.960190E-02 |
| N0-vs-N1 |
4.174600E-01 |
| N0-vs-N2 |
5.395800E-01 |
| N1-vs-N2 |
4.532200E-01 |
|
|
